The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice

Journal of Investigative Dermatology

Volumn 128, Issue 9, 2008, Pages 2310-2315

  Pfefferle, Regina ^a   Marcuzzi, Gian Paolo ^a   Akgül, Baki ^a   Kasper, Hans Udo ^a   Schulze, Falko ^a   Haase, Ingo ^a   Wickenhauser, Claudia ^a   Pfister, Herbert ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; GLYCOPROTEIN E2;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE SEVERITY; DYSPLASIA; EPIDERMIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INFUNDIBULUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN DEFECT; SKIN TUMOR; SPINDLE CELL; TRANSGENIC MOUSE; TUMOR GROWTH; ULTRAVIOLET RADIATION; WART VIRUS;

EID: 49549122678     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.73     Document Type: Article

References (35)

1. Akgül B, Cooke JC, Storey A (2006) HPV-associated skin disease. J Pathol 208:165-75
2. Akgül B, Karle P, Adam M, Fuchs PG, Pfister HJ (2003) Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8. Virology 308:279-90
3. Armstrong BK, Kricker A (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol 63:8-18
4. Bernerd F, Del Bino S, Asselineau D (2001) Regulation of keratin expression by ultraviolet radiation: differential and specific effects of ultraviolet B and ultraviolet a exposure. J Invest Dermatol 117:1421-9
5. Boner W, Taylor ER, Tsirimonaki E, Yamane K, Campo MS, Morgan IM (2002) A functional interaction between the human papillomavirus 16 transcription/ replication factor E2 and the DNA damage response protein TopBP1. J Biol Chem 277:22297-303
6. Coussens LM, Hanahan D, Arbeit JM (1996) Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol 149:1899-917
7. Desaintes C, Goyat S, Garbay S, Yaniv M, Thierry F (1999) Papillomavirus E2 induces p53-independent apoptosis in HeLa cells. Oncogene 18:4538-45
8. Diepgen TL, Mahler V (2002) The epidemiology of skin cancer. Br J Dermatol 146(Suppl 61):1-6
9. Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681-91
10. Feltkamp MC, Broer R, di Summa FM, Struijk L, van der Meijden E, Verlaan BP et al. (2003) Seroreactivity to epidermodysplasia verruciformis- related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 63:2695-700
11. Francis DA, Schmid SI, Howley PM (2000) Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. J Virol 74:2679-86
12. Frattini MG, Laimins LA (1994) Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc Natl Acad Sci USA 91:12398-402
13. Fuchs P, Horn S, Iftner T, May M, Stubenrauch F, Pfister H (1993) Molecular Biology of Epidermodysplasia Verruciformis-Associated Human Papillomaviruses. Weinheim: VCH, 517-29
14. Hadaschik D, Hinterkeuser K, Oldak M, Pfister HJ, Smola-Hess S (2003) The papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J Virol 77:5253-65
15. Hammes A, Schedl A (2000) Generation of Transgenic Mice from Plasmids, BACs and YACs. New York: Oxford University Press, 217-45
16. Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R (2006) Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 54:290-300
17. Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM et al. (2004) Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 150:949-57
18. Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH (1993) FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14:2353-8
19. Iftner T, Fuchs PG, Pfister H (1989) Two independently transforming functions of human papillomavirus 8. Curr Top Microbiol Immunol 144:167-73
20. Jablonska S, Majewski S (1994) Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol 186:157-75
21. Lee D, Kim JW, Kim K, Joe CO, Schreiber V, Menissier-De Murcia J et al. (2002) Functional interaction between human papillomavirus type 18 E2 and poly(ADP-ribose) polymerase 1. Oncogene 21:5877-85
22. Leykauf K, Kabsch K, Gassler N, Gissmann L, Alonso A, Schenkel J (2008) Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern. Transgenic Res 17:1-8
23. Lowy DR, Howley PM (2002) Papillomaviruses. 4th edn, vol. 2 Lippincott Williams & Williams: Philadelphia, 2231-64
24. Masini C, Fuchs PG, Gabrielli F, Stark S, Sera F, Ploner M et al. (2003) Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 139:890-4
25. Massimi P, Pim D, Bertoli C, Bouvard V, Banks L (1999) Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 18:7748-54
26. Oldak M, Smola H, Aumailley M, Rivero F, Pfister H, Smola-Hess S (2004) The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes. J Virol 78:10738-46
27. Orth G (2006) Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 18:362-74
28. Pfister H (2003) Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31:52-6
29. Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, Smyth N et al. (2005) Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 65:1394-400
30. Stark S, Petridis AK, Ghim SJ, Jenson AB, Bouwes Bavinck JN, Gross G et al. (1998) Prevalence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 111:696-701
31. van Hogerlinden M, Rozell BL, Toftgard R, Sundberg JP (2004) Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-kappaB signaling. J Invest Dermatol 123:101-8
32. Vasioukhin V, Degenstein L, Wise B, Fuchs E (1999) The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc Natl Acad Sci USA 96:8551-6
33. Webster K, Parish J, Pandya M, Stern PL, Clarke AR, Gaston K (2000) The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J Biol Chem 275:87-94
34. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD, Howley PM (2000) Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J 19:5762-71
35. You J, Croyle JL, Nishimura A, Ozato K, Howley PM (2004) Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117:349-60